An interventional study of Yoga in Young Adult Cancer and Young Adult Oncology, sponsored by University of Calgary. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-04-06.
Sponsored by University of Calgary · Not applicable, Interventional, and Supportive care
Yoga may enhance physical and psychological outcomes among young adults affected by cancer. Yet, yoga has rarely been studied in this population. We developed and piloted a yoga program, which is now ready for implementation and evaluation. This single-group, mixed-methods project will explore effectiveness and implementation of the yoga program.
9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.
This study's planned enrollment of 500 is above the median of 50 across 7,253 interventional studies indexed under Neoplasms.
Browse Neoplasms studies →University of Calgary is the lead sponsor of 686 studies on the registry; 189 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 2 (20%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Participants receive online, group-based yoga classes 2 times/week for 60 minutes/class over 12 weeks.
Behavioral: Yoga
Participants receive the yoga program, which is delivered by a trained yoga instructor (completed at least a 200-hour yoga teacher training, Yoga Thrive Teacher Training Certification (or similar), and/or practical experience working with individuals affected by cancer). The first class of the week is comprised of 45 minutes of gentle, progressive, hatha-based yoga sequencing and postures with the last 15 minutes focused on guided behaviour change and mindfulness techniques that varies week-to-week, based on the participants in the class. The second class of the week is 60 minutes of gentle, yin-based yoga sequencing and postures with an element of opening and relaxing.
Reach
The number of people who participate, and reasons why or why not.
Time frame: Through study completion, an average of 5 years
Attendance
Number of classes attended out of the number of classes offered by study staff.
Time frame: Through study completion, an average of 5 years
Adherence
Number of classes attended out of the number of classes offered by study staff.
Time frame: Through study completion, an average of 5 years
Missing data
Percentage of missing data on quantitative measures and completion of qualitative interviews.
Time frame: Through study completion, an average of 5 years
Barriers and facilitators to exercise participation
Change in Barrier Self-Efficacy Scale (1). Scale range 0-100; higher scores indicates less barriers to participation.
Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)
Physical activity levels
Changes in Godin Leisure Time Scale (2). Individuals indicate how many times per week and how long per session they exercise at certain intensity (mild, moderate, high). Higher scores indicate higher levels of physical activity.
Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)
Fatigue
Change in Functional Assessment of Chronic Illness Therapy - Fatigue Scale (3). Scale range 0-4; selected items are reverse scored; higher score indicate less fatigue.
Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)
Cognition
Changes in Functional Assessment of Cancer Therapy - Cognitive Scale (4). Scale range 1-4; some items are reversed scored; higher scores indicate less cognitive impairment.
Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)
Cancer-related symptoms
Change in Edmonton Symptom Assessment Scale (5). Scale range 0-10; lower scores indicate fewer/less severe symptoms.
Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)
General health-related quality of life
Change in EuroQual - 5Dimensions (EQ-5D) Scale (6). Scale range 1-5 with lower scores indicating greater quality of life; visual analogue scale range 0-100 with higher scores indicating greater quality of life.
Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)
General well-being
Change in Functional Assessment of Cancer Therapy - General Scale (7). Scale range 0-4; selected items are reversed scored; higher scores indicate greater quality of life.
Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)
Mindfulness
Change in Mindful Attention Awareness Scale (8). Scale range 1-6; higher scores indicate higher levels of dispositional mindfulness.
Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)
Self-compassion
Change in Self-Compassion Scale (9). Scale range 1-5; higher scores indicate greater self-compassion.
Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)
Stress
Change in Perceived Stress Scale (10). Scale range 0-4; some items are reverse scored; higher scores indicate more perceived stress.
Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)
Group identification
Change in Group Identification Scale (11). Scale range 1-7; higher scores indicate greater identification with the group.
Time frame: Post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)
Balance
Change in one legged stance test (seconds) (see 12).
Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)
Shoulder range of motion
Change in active shoulder flexion range of motion (degrees) (see 12).
Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)
Lower extremity flexibility
Change in sit-and-reach test (cm) (see 12).
Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)
Functional performance
Change in sit-to-stand (number of repetitions in 30 seconds) (see 12).
Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)
Aerobic endurance
Change in 2 minute step test (steps) results (see 12).
Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)
Adverse events
Adverse events will be defined as any negative effect caused (or suspected to be caused by) the yoga program.
Time frame: Through study completion, an average of 5 years
Time to implement and deliver
Time and expertise to deliver the intervention and physical assessments will be tracked.
Time frame: Through study completion, an average of 5 years
Yoga program fidelity
Fidelity of the physical activity program implementation will be assessed via randomly video-auditing a subset of classes.
Time frame: Through study completion, an average of 5 years
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Calgary